Found 792 clinical trials
Proton Radiation Therapy Registry
The Johns Hopkins Proton Therapy center is establishing a registry to capture the full 3D radiation dosimetry delivered to the patient, baseline clinical data, and disease, toxicity and quality of life outcomes. The goal is to have all patients treated at the proton center to be included in the registry …
- 0 views
- 16 Feb, 2024
- 4 locations
Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes
This is a translational study in patients with operated early breast cancer of Luminal A or Luminal B sub types.The Hellenic Cooperative Oncology Group (HeCOG) has designed an observational biomarker-driven study in patients with Luminal A or Luminal B breast cancer, with the aim to collect valuable biological material from …
- 0 views
- 16 Feb, 2024
- 1 location
Cohort Study of Pancreatic Cancer Risk
Mayo Clinic is part of a national Pancreatic Cancer Detection Consortium (PCDC)[1] which aims to establish a high-risk cohort with the goal of validating blood biomarkers (discovered/developed outside of this protocol) using the samples collected serially (annually) that predict or detect pancreatic cancer prior to clinical diagnosis.
- 0 views
- 16 Feb, 2024
- 1 location
A Study to Identify Breast Cancer (IDBC)
Detecting cancer as early as possible is key to achieving positive outcomes in response to diagnosis and treatment. The current project is aimed at validating a novel blood-based breast cancer identification test (Syantra DX Breast Cancer) that has been developed by Syantra Inc.
- 0 views
- 05 Aug, 2020
Prospective Research for Elderly (≥65 Years Old) Early Breast Cancer Patients (EEBC)
Previous studies on breast cancer have almost excluded elderly breast cancer patients, and conventional treatment schemes cannot meet the clinical diagnosis and treatment needs of elderly breast cancer patients.
- 0 views
- 16 Jun, 2023
- 1 location
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
This study is for verification of predictive biomarkers for pancreatic cancer treatment using multi-center liquid biopsy.
- 0 views
- 16 Feb, 2024
- 1 location
Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer
To identify factors associated with the risk of death and morbidity among patients with cancer. Methodology Retrospective inclusion of n=200 cancer patients hospitalized for COVID and n=400 matched (based on age, gender, and comorbidity) non-cancer patients hospitalized for COVID.
- 0 views
- 16 Feb, 2024
- 5 locations
A Prospective Cohort Study of Chinese Patients With Pulmonary Nodules: Prediction of Lung Cancer Using Noninvasive Biomarkers
The diagnostic markers once validated can be used as broad screening tools for lung cancer.
- 0 views
- 16 Feb, 2024
- 6 locations
Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce
This study investigates the impact of the COVID-19 pandemic on the psychosocial health of employees of MD Anderson Cancer Center. Epidemics have been shown to promote psychological stress among medical staff in high risk areas, which may lead to mental health problems.
- 0 views
- 16 Feb, 2024
- 1 location
Validation of the Italian Version of the PRO-CTCAE
In particular, for the first time this study will validate the tool for individual types of cancer and will provide information on psychometric properties based on the type of treatment used in clinical practice.
- 0 views
- 16 Feb, 2024
- 25 locations